###begin article-title 0
Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction
###end article-title 0
###begin p 1
###xml 33 60 33 60 <email xmlns:xlink="http://www.w3.org/1999/xlink">s.heymans@cardio.unimaas.nl</email>
CORRESPONDENCE Stephane Heymans: s.heymans@cardio.unimaas.nl
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1100 1105 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1181 1186 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
###xml 1192 1196 <span type="species:ncbi:10090">mice</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
The matricellular protein SPARC (secreted protein, acidic and rich in cysteine, also known as osteonectin) mediates cell-matrix interactions during wound healing and regulates the production and/or assembly of the extracellular matrix (ECM). This study investigated whether SPARC functions in infarct healing and ECM maturation after myocardial infarction (MI). In comparison with wild-type (WT) mice, animals with a targeted inactivation of SPARC exhibited a fourfold increase in mortality that resulted from an increased incidence of cardiac rupture and failure after MI. SPARC-null infarcts had a disorganized granulation tissue and immature collagenous ECM. In contrast, adenoviral overexpression of SPARC in WT mice improved the collagen maturation and prevented cardiac dilatation and dysfunction after MI. In cardiac fibroblasts in vitro, reduction of SPARC by short hairpin RNA attenuated transforming growth factor beta (TGF)-mediated increase of Smad2 phosphorylation, whereas addition of recombinant SPARC increased Smad2 phosphorylation concordant with increased Smad2 phosphorylation in SPARC-treated mice. Importantly, infusion of TGF-beta rescued cardiac rupture in SPARC-null mice but did not significantly alter infarct healing in WT mice. These findings indicate that local production of SPARC is essential for maintenance of the integrity of cardiac ECM after MI. The protective effects of SPARC emphasize the potential therapeutic applications of this protein to prevent cardiac dilatation and dysfunction after MI.
###end p 3
###begin p 4
Abbreviations used: ECM, extracellular matrix; LV, left ventricle; MI, myocardial infarction; mRNA, messenger RNA; shRNA, short hairpin RNA; SMC, smooth muscle cell.
###end p 4
###begin p 5
M.W.M. Schellings and D. Vanhoutte contributed equally to this paper.
###end p 5
###begin p 6
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
SPARC (secreted protein, acidic and rich in cysteine, also called osteonectin and BM-40) belongs to the group of matricellular proteins, which are nonstructural proteins present in the extracellular matrix (ECM). Although they do not contribute directly to tissue integrity, they are potent modulators of cellular function. SPARC is involved in tumor progression and wound healing via its regulation of cell-ECM interactions and ECM production (1, 2). Expression of SPARC is increased after myocardial infarction (MI) and is spatially and temporally related to the formation of a fibrous scar (3, 4). Although previous studies indicate a role for SPARC in cutaneous wound healing (5, 6), evidence for a specific role for SPARC in granulation and ECM formation in an infarcted heart is lacking.
###end p 6
###begin p 7
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 885 886 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
Healing after MI requires a tightly regulated process of wound healing and scar formation that consists of three overlapping phases. The initial inflammatory phase for removal of dead tissue is followed rapidly by the formation of granulation tissue, which is rich in leukocytes, new vessels, and proliferating fibroblasts. The final, maturation phase is characterized by a regression of granulation tissue and a progressive maturation of the collagenous ECM. Alterations in this well orchestrated response to myocardial necrosis leads to adverse infarct healing, cardiac rupture, and cardiac dysfunction (7). SPARC modulates ECM turnover in part through its effect on collagen synthesis, extracellular proteases, and growth factors (1). In addition, SPARC binds to TGF-beta receptor type II in the presence of TGF-beta and thereby affects its downstream signaling in mesangial cells (8).
###end p 7
###begin p 8
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
Because SPARC is increased after MI and can affect ECM organization, we hypothesized that SPARC regulates infarct healing and ECM maturation after MI and might thereby protect against cardiac rupture and dysfunction. Our data reveal that loss of SPARC results in the formation of a disorganized scar and immature collagen matrix after MI. Adverse infarct healing in SPARC-null hearts evolves into increased cardiac rupture and dysfunction, whereas adenoviral overexpression of SPARC protects against cardiac dilatation and failure after MI. SPARC is therefore a promising target to obtain proper infarct healing and collagen maturation and prevent cardiac rupture, dilatation, and dysfunction after MI.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
SPARC expression is induced after MI
###end title 10
###begin p 11
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 450 458 450 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 539 547 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 580 588 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 634 649 634 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 794 805 790 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E&#8211;G</xref>
###xml 843 854 839 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, H&#8211;J</xref>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
To assess the expression of SPARC in the cardiac healing process, we examined SPARC protein expression in myocardial tissue of WT mice after MI. Immunoblotting of SPARC in noninfarcted remote left ventricle (LV) only revealed a moderate increase of SPARC protein expression at 3 d after MI (Fig. 1 A). In contrast, and concordant with previous findings (3, 4), SPARC protein levels were strongly increased in the infarcted LV at 7 and 14 d after MI (Fig. 1 A). Immunohistochemistry confirmed that SPARC was low to absent in sham-operated (Fig. 1 B) and in noninfarcted remote LV (Fig. 1 C) but abundantly present in the infarcted LV (Fig. 1, C and D). Double immunohistochemistry revealed that SPARC mainly colocalized with alpha-smooth muscle actin-positive cells (infiltrating myofibroblast; Fig. 1, E-G) and CD45-immunoreactive leukocytes (Fig. 1, H-J). Thus, SPARC protein showed a localized deposition contemporaneous with the formation of granulation tissue and progressive maturation of the infarct scar.
###end p 11
###begin p 12
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SPARC expression is induced after MI.</bold>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
SPARC expression is induced after MI. (A) SPARC protein is increased after MI in mice. Representative Western blots of SPARC in remote and infarcted LV from WT mice at 3, 7, and 14 d after MI (n = 4 per time point; *, P < 0.05). (B-D) SPARC immunofluorescent staining (green) is absent in sham-operated hearts (B) and remote LV (R-LV), gradually increases in the infarct border LV (IB-LV; C), and is strongly up-regulated in the infarcted LV (I-LV) 7 d after MI (C and D). (E-J) SPARC expression (E and H) colocalizes with alpha-smooth muscle cell (SMC) actin-positive myofibroblasts (F and G) and CD45 immunoreactive leukocytes (I and J) in the infarcted LV of WT infarcted hearts 7 d after MI. The insets in H-J show detailed SPARC and CD45 immunoreactive leukocytes. Error bars represent the mean +/- SEM. Bars: (B-D, H, and J) 100 mum; (E-G) 50 mum.
###end p 12
###begin title 13
Increased SPARC after MI protects against cardiac rupture and dysfunction
###end title 13
###begin p 14
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 369 380 369 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A&#8211;C</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 974 979 972 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
To evaluate the function of SPARC in ECM maturation, we used a model of permanent coronary occlusion. The absence of SPARC was associated with a significantly increased incidence of cardiac rupture after MI: 41% (13/32) of SPARC-null mice (males, 8/12; females, 5/20) compared with 9% (3/34) of WT mice (males, 2/14; females, 1/20) died as a result of cardiac rupture (Fig. 2, A-C). Increased lung weight/body weight ratios at 3 d after MI in SPARC-null compared with WT mice pointed toward cardiac dysfunction in SPARC-null mice (Table I). Four male SPARC-null mice that did not die from cardiac rupture displayed severe shortness of breath within 7 d. Two of them died prematurely (6 d after MI), whereas the other two were killed after echocardiography at 7 d after MI. The fractional shortening of these two mice pointed toward severe systolic dysfunction (7.1 +/- 3.9%), which was associated with significantly increased lung weight/body weight ratios in the four male SPARC-null mice surviving cardiac rupture (14.1 +/- 0.7 vs. 9.7 +/- 1.3 in WT mice; P < 0.05).
###end p 14
###begin p 15
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Absence of <italic>SPARC</italic> results in cardiac rupture and dysfunction.</bold>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 910 915 910 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 929 930 929 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 966 967 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
Absence of SPARC results in cardiac rupture and dysfunction. (A) Kaplan-Meier curve showing that targeted deletion of SPARC resulted in decreased survival of SPARC-null (mainly male) compared with WT mice after MI (*, P < 0.05). Decreased survival was mainly caused by cardiac rupture. Two male SPARC-null mice had to be killed at 7 d after MI because of severe shortness of breath and, therefore, were not included in the survival curve. (B and C) Histological analysis of ruptured LV of male SPARC-null infarcted hearts (hematoxylin and eosin stained) revealing rupture site (B, arrows), intramural hemorrhages of the infarcted ventricular wall (C, arrows), and massive infiltration of erythrocytes and inflammatory cells (C) and thrombi (B and C, asterisks) at 3 d after MI. (D-G) Decreased survival is associated with depressed cardiac contractility (D) and relaxation (E) during infusion of dobutamine in SPARC-null female (n = 7) in comparison with female WT (n = 9) mice 14 d after MI, whereas systolic blood pressure (BP; F) and heart rate (G) did not differ significantly (*, P < 0.05). bpm, beats per minute. Error bars represent the mean +/- SEM. Bars: (B) 200 mum; (C) 100 mum.
###end p 15
###begin p 16
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Functional analysis of WT and SPARC-null mice after MI
###end p 16
###begin p 17
M, male; F, female; FS, fractional shortening; LVIDd, left ventricular internal diameter diastole; PWd, posterior wall diastole; IVSd, intraventricular septum diastole; HW, heart weight; BW, body weight; and LW, lung weight.
###end p 17
###begin p 18
P < 0.05 in SPARC-null versus WT infarcts.
###end p 18
###begin p 19
P < 0.05 in infarcted versus sham.
###end p 19
###begin p 20
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 325 328 325 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 338 341 338 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">min</sub>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 423 438 423 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, D and E</xref>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 608 623 608 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, D and E</xref>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 769 784 769 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, F and G</xref>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
Left ventricular pressure and heart rate were similar in sham-operated and infarcted WT and SPARC-null mice at baseline. Systolic function, as measured by echocardiography, was reduced in infarcted compared with sham-operated mice at 3, 7, and 14 d after MI but to a similar extent in both genotypes (Table I). Baseline dP/dtmax and dP/dtmin did not differ between infarcted female SPARC-null and WT mice at 14 d after MI (Fig. 2, D and E). However, hemodynamic stress induced by dobutamine increased contractility and relaxation in infarcted female WT mice but to a lesser extent in female SPARC-null mice (Fig. 2, D and E). Systolic blood pressure and heart rate did not differ significantly after dobutamine infusion between infarcted female WT and SPARC-null mice (Fig. 2, F and G). Although SPARC deficiency does not affect cardiac structure or performance of the heart under physiological conditions, increased levels of SPARC appear to play a pivotal role in the healing process by maintenance of the structural integrity of the heart after MI.
###end p 20
###begin p 21
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC2</italic>
###xml 561 566 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 733 741 733 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 757 762 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC1</italic>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hevin</italic>
###xml 1037 1042 1037 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1166 1174 1166 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
To investigate whether the absence of SPARC or gender differences resulted in compensatory changes in expression of SPARC-related factors before the onset of cardiac rupture, we determined transcript levels in male and female sham and 3-d-old infarcted hearts of SPARC-null and WT mice. SMOC1, SMOC2, and Hevin were selected because previous studies described their expression in the heart (9-11), but little is known about the biological function of these proteins in the heart. Interestingly, transcript levels of SMOC2 were significantly increased in WT and SPARC-null female sham mice in comparison with male sham mice, whereas its expression decreased significantly after MI with no significant differences between the genders (Table II). In contrast, SMOC1 expression significantly increased 3 d after MI but did not significantly differ between the genders or genotypes. Transcript levels of Hevin slightly decreased after MI, reaching significance in the infarcted female WT mice in comparison with the respective sham. Finally, SPARC transcript levels significantly increased at 3 d after MI in WT mice but did not significantly differ between the genders (Table II).
###end p 21
###begin p 22
Transcript levels of SPARC-related factor messenger RNAs (mRNAs)
###end p 22
###begin p 23
M, male; F, female; ND, not detectable. Numbers are in arbitrary units.
###end p 23
###begin p 24
P < 0.05 in MI group versus respective sham.
###end p 24
###begin p 25
P < 0.05 between males and females of the same genotype.
###end p 25
###begin p 26
###xml 35 39 <span type="species:ncbi:10090">mice</span>
P < 0.05 between WT and SPARC-null mice of the same gender.
###end p 26
###begin title 27
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
SPARC-null infarcts exhibit disorganized granulation tissue and deficient scar maturation
###end title 27
###begin p 28
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 74 83 74 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 215 226 215 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A&#8211;D</xref>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 449 458 449 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
Infarct size did not significantly differ between WT and SPARC-null mice (Table III). Histopathological analysis of infarcts revealed a disorganized scar tissue with diffuse RBC infiltration in SPARC-null infarcts (Fig. 3, A-D). Adverse infarct healing in SPARC-null mice was not related to significant differences in inflammation or vascular density, except for the area of myofibroblasts, which was significantly increased in SPARC-null infarcts (Table III).
###end p 28
###begin p 29
Histological analysis of the infarcted area
###end p 29
###begin p 30
O-R, orange-red; Y-G, yellow-green.
###end p 30
###begin p 31
P < 0.05 in SPARC-null versus WT infarcts at corresponding time after MI.
###end p 31
###begin p 32
P < 0.05 in TGF-beta-treated infarcts versus untreated infarcts at the corresponding time after MI.
###end p 32
###begin p 33
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Adverse wound healing in <italic>SPARC</italic>-null mice.</bold>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 691 696 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 834 839 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 854 855 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
Adverse wound healing in SPARC-null mice. (A-D) Hematoxylin and eosin staining revealed a disorganized granulation tissue with increased RBC infiltration in male SPARC-null (C and D) versus WT (A and B) 7-d-old infarcts. (E-K) Abnormal collagen formation in SPARC-null infarcts. (E-H) Sirius red staining did not indicate substantial differences in the amount of collagen deposition between WT (E) and SPARC-null (G) infarcts at 14 d after MI. Sirius red polarization microscopy revealed well aligned and tightly packed (orange-red) collagen fibers in WT (F) but less mature fibers (yellow-green) in SPARC-null infarcts (H). (I-K) Ultrastructural analysis confirmed a disorganized matrix in SPARC-null (J) in comparison with WT (I) infarcts, which was associated with the deposition of smaller collagen fibrils in the infarct zone of SPARC-null mice (K; n = 3). Bars: (A, C, E, and G) 200 mum; (B and D) 50 mum; (I and J) 5 mum; (K) 500 nm.
###end p 33
###begin p 34
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 322 333 322 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E&#8211;H</xref>
###xml 335 344 335 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 587 598 587 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, I&#8211;K</xref>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Sirius red polarization microscopy of collagen fibers revealed a predominance of loosely assembled (yellow-green) collagen fibers in SPARC-null infarcts at 14 d (ratio of orange-red/yellow-green birefringent collagen), which was in contrast to the well aligned and thick tightly packed (orange-red) fibers in WT infarcts (Fig. 3, E-H; Table III). Ultrastructural analysis confirmed a disorganized and immature collagen matrix in SPARC-null infarcts, as indicated by the decreased diameter of collagen fibrils, which was in contrast to the well structured collagen matrix in WT infarcts (Fig. 3, I-K). Ultrastructural and histological analysis of the cardiac matrix in SPARC-null and WT sham mice did not reveal significant differences.
###end p 34
###begin p 35
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 152 167 152 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and G</xref>
###xml 169 178 169 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 204 219 204 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">collagen type I</italic>
###xml 224 232 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">type III</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
The absence of SPARC did not affect collagen synthesis, as is shown by the lack of significant differences in the fraction Sirius red-stained collagen (Fig. 3, E and G; Table III) or transcript levels of collagen type I and type III (Table S1, available at ) in SPARC-null compared with WT infarcts. Thus, increased cardiac rupture and dysfunction in SPARC-null mice are related, at least in part, to deficient maturation of the scar after MI.
###end p 35
###begin title 36
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
Adenoviral overexpression of SPARC protects against cardiac dilatation and dysfunction after acute MI
###end title 36
###begin p 37
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 432 447 432 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A and B</xref>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl4">Table IV</xref>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl5">Table V</xref>
###xml 680 691 680 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C-F</xref>
###xml 693 700 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl5">Table V</xref>
###xml 877 884 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl5">Table V</xref>
###xml 1067 1072 1063 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
To investigate whether overexpression of SPARC could prevent cardiac dysfunction after MI, we enhanced SPARC expression in WT mice by injection of a replication-deficient adenovirus harboring mouse SPARC (AdSPARC) 2 d before MI. Subsequently, there was a 2.8-fold increase in expression of SPARC in plasma and a 2.6-fold increase of SPARC expression in the infarct area at 14 d after MI in comparison to control AdR5-injected mice (Fig. 4, A and B). The increased levels of SPARC prevented cardiac dilatation and dysfunction after MI (Table IV) without alteration of infarct size (Table V). SPARC significantly increased collagen deposition and birefringence in the infarct zone (Fig. 4, C-F; Table V) but did not affect the amount of CD45-positive leukocytes, alpha-smooth muscle actin-positive myofibroblasts, and coronary vessels in comparison to control AdR5-treated mice (Table V). These findings were corroborated by the increased transcript levels of ECM proteins in the infarcts of mice treated with AdSPARC (Table S2, available at ). Thus, overexpression of SPARC protects against adverse collagen remodeling, which is associated with reduced ventricular dilatation and failure after MI.
###end p 37
###begin p 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SPARC</italic> overexpression increases collagen deposition and quality after MI.</bold>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
SPARC overexpression increases collagen deposition and quality after MI. (A and B) Representative Western blots showing a 2.8-fold increase of SPARC in plasma (A) and a 2.6-fold increase of SPARC in the infarct area (B) of AdSPARC-treated WT mice in comparison with AdR5-treated WT mice at 14 d after MI (n = 4; *, P < 0.05). (C-F) Sirius red staining and polarization microscopy revealed increased collagen deposition in AdSPARC-treated (D) in comparison with AdR5-treated WT infarcts (C) and more well aligned and tightly packed (orange-red) collagen fibers in AdSPARC-treated (F) in comparison with AdR5-treated WT infarcts (E). Error bars represent the mean +/- SEM. Bars: (C and D) 2 mm; (E and F) 200 mum.
###end p 38
###begin p 39
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Functional analysis of WT mice treated with AdR5 or AdSPARC virus
###end p 39
###begin p 40
FS, fractional shortening; LVIDd, left ventricular internal diameter diastole; LVIDs, left ventricular internal diameter systole; PWd, posterior wall diastole IVSd, intraventricular septum diastole; HW, heart weight; BW, body weight; and LW, lung weight.
###end p 40
###begin p 41
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
P < 0.05 in infarcted (MI) versus sham-operated mice or AdR5 versus AdSPARC sham-operated mice.
###end p 41
###begin p 42
P < 0.05 in AdvSPARC infarcts versus AdR5 infarcts.
###end p 42
###begin p 43
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Histological analysis of the infarcted area of AdR5- and AdSPARC-treated mice
###end p 43
###begin p 44
O-R, orange-red; Y-G, yellow-green.
###end p 44
###begin p 45
P < 0.05 in AdvSPARC infarcts versus AdR5 infarcts.
###end p 45
###begin title 46
SPARC modulates TGF-beta signaling
###end title 46
###begin p 47
###xml 192 194 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 312 320 309 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 517 525 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 633 641 627 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 895 896 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1008 1009 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1102 1103 1079 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1165 1173 1139 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 1256 1261 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1354 1359 1328 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
We asked whether the increased collagen deposition found in the infarcts of SPARC-overexpressing mice was associated with altered signaling of TGF-beta, which is a known profibrotic cytokine (12). The levels of phosphorylated and total Smad2 were significantly higher in the infarcts of AdSPARC-treated WT mice (Fig. 5 A). These results were concordant with experiments in vitro, which showed that addition of recombinant SPARC increased Smad2 phosphorylation at baseline as well as after stimulation with TGF-beta1 (Fig. 5 B). Inhibition of SPARC by short hairpin RNA (shRNA) resulted in an 80% decrease in levels of SPARC protein (Fig. 5 C). Although treatment with 1 ng/ml TGF-beta resulted in a significant increase in the ratio of phosphorylated Smad2 (p-Smad2) to total Smad2 protein in control fibroblasts (100 +/- 4% in control compared with 272 +/- 30% in TGF-beta-treated fibroblasts; n = 5; P < 0.05), the decrease in SPARC significantly blunted the ratio of p-Smad2/Smad2 at baseline (66 +/- 8%; n = 6; P < 0.05 compared with WT fibroblasts) and after treatment with TGF-beta (234 +/- 14%; n = 5; P < 0.05 compared with TGF-beta-treated WT fibroblasts; Fig. 5 C). We did not find significant differences in Smad2 phosphorylation between WT and SPARC-null infarcts, a result which might reflect the increased presence of myofibroblasts in the SPARC-null infarcts. Together, these data confirm a role for SPARC in the regulation of TGF-beta signaling.
###end p 47
###begin p 48
###xml 0 52 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SPARC and TGF-&#946; cooperate during infarct healing.</bold>
###xml 182 183 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 368 369 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 760 761 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 895 900 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 968 973 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1127 1132 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1245 1250 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1472 1477 1451 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1644 1649 1623 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1490 1494 <span type="species:ncbi:10090">mice</span>
SPARC and TGF-beta cooperate during infarct healing. (A) Representative Western blot showing increased phosphorylated and total Smad2 levels in the infarcts of AdSPARC-treated mice (n = 9; *, P < 0.05). (B) Representative Western blot showing that addition of recombinant mouse SPARC activated Smad2 signaling and augmented the Smad2-activating potential of TGF-beta (n = 6; *, P < 0.05). (C) The top blot is a representative Western blot indicating that shRNA against SPARC resulted in an 80% decrease in levels of SPARC protein. The blots are representative Western blots showing that Smad2 phosphorylation in shRNA-treated cardiac fibroblasts was significantly decreased at baseline levels (left) and after 15 min of stimulation by 1 ng/ml TGF-beta (right; n = 5 per group; *, P < 0.05). (D) Survival curve showing that infusion of TGF-beta protected against cardiac rupture after MI in male SPARC-null mice (1 out of 7 mice) in comparison with saline-treated male SPARC-null mice (8 out of 12 mice; *, P < 0.05). (E, F, I, and J) Hematoxylin and eosin staining revealed striking differences between TGF-beta-treated WT and SPARC-null mice 7 d after MI. In WT mice, infusion of TGF-beta did not significantly affect wound healing, whereas in SPARC-null animals it stimulated ECM production in the infarct zone. (G, H, K, and L) Sirius Red staining and Sirius Red polarization microscopy revealed no apparent differences in collagen deposition between TGF-beta1-treated SPARC-null and WT mice, whereas the difference in well aligned and tightly packed (orange-red) collagen fibers in WT infarcts (H), but less mature fibers (yellow-green) in SPARC-null infarcts (L), was preserved. Error bars represent the mean +/- SEM. Bars: (E, G-I, K, and L) 200 mum; (F and J) 50 mum.
###end p 48
###begin title 49
###xml 57 62 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Infusion of TGF-beta protects against cardiac rupture in SPARC-null mice
###end title 49
###begin p 50
###xml 145 150 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 245 250 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 265 270 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
TGF-beta is strongly implicated in infarct healing and remodeling after MI. To investigate whether aberrant TGF-beta signaling in the absence of SPARC is involved in the adverse infarct healing and increased cardiac rupture after MI observed in SPARC-null animals, SPARC-null and WT mice were treated with TGF-beta.
###end p 50
###begin p 51
###xml 66 71 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 198 203 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 215 223 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 339 344 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 358 369 349 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, E&#8211;L</xref>
###xml 371 380 362 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 471 480 462 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 541 546 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 792 797 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 819 820 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 836 847 817 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, E&#8211;L</xref>
###xml 849 858 830 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 968 979 946 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, E&#8211;L</xref>
###xml 981 990 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
Administration of TGF-beta significantly improved the survival of SPARC-null animals by its diminution of cardiac rupture (1 out of 7 in TGF-beta-treated compared with 8 out of 12 in saline-treated SPARC-null mice; Fig. 5 D). Histological analysis revealed increased deposition of collagen in TGF-beta-treated compared with saline-treated SPARC-null hearts (Fig. 5, E-L; Table III), but no significant differences in inflammation or blood vessel formation were observed (Table III). Improved collagen maturation by infusion of TGF-beta into SPARC-null infarcted mice was demonstrated by the significantly increased numbers of thick orange-red collagen fibers (ratio of orange-red/yellow-green birefringent collagen, 4.5 +/- 1.2 in TGF-beta-treated compared with 2.2 +/- 0.4 in saline-treated SPARC-null infarcted mice; n = 7; P < 0.05; Fig. 5, E-L; Table III). Administration of TGF-beta did not significantly affect wound healing or collagen formation in WT animals (Fig. 5, E-L; Table III).
###end p 51
###begin title 52
DISCUSSION
###end title 52
###begin p 53
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 538 543 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
This study indicates a crucial role for SPARC in infarct healing and collagen formation after MI. The absence of SPARC was associated with adverse healing and deficient maturation of collagen with increased cardiac rupture and dysfunction after MI. Importantly, adenoviral-mediated overexpression of SPARC (AdSPARC) in WT mice, resulting in increased plasma and cardiac levels of SPARC, improved collagen maturation and prevented cardiac dysfunction and dilatation after MI. Moreover, treatment with TGF-beta prevented cardiac rupture in SPARC-null infarcted mice, a result which underscores our data in vitro and in vivo showing that exogenous SPARC regulates TGF-beta signaling.
###end p 53
###begin p 54
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 800 805 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC1</italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC2</italic>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hevin</italic>
###xml 964 965 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1083 1088 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC2</italic>
###xml 1293 1298 1293 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC2</italic>
###xml 1443 1448 1443 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMOC1</italic>
###xml 1645 1650 1645 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hevin</italic>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1274 1278 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
Expression of SPARC increases progressively after MI and is seen primarily in inflammatory cells and fibroblasts (1, 4), data which indicates a role for SPARC during healing of the infarct scar. The increased cardiac rupture and dysfunction that we observed appeared to coincide with the disorganized and fragmented granulation tissue as well as abnormal collagen maturation. Cardiac rupture mainly occurred in male mice. Hormonal status, higher blood pressure, and increased physical activity during the night may predispose to the increased cardiac rupture, dysfunction, and mortality in male compared with female mice after MI (13-16). To investigate whether differences in expression of SPARC or SPARC-related factors may influence the phenotype seen after MI, we determined transcript levels of SPARC and the SPARC-related factors SMOC1, SMOC2, and Hevin in males and females of both genotypes. Because these SPARC-related factors are expressed in the heart (9-11) and Hevin is involved in collagen assembly (17), these proteins may be implicated in infarct remodeling. Lack of SPARC did not result in compensatory changes of SPARC-related factors. However, sham WT and SPARC-null female mice displayed increased transcript levels of SMOC2 in comparison with male sham mice. In contrast, SMOC2 transcript levels did not differ significantly between the genders at 3 d after MI, indicating that SMOC2 may not protect female mice after MI. SMOC1 transcript levels were strongly increased at 3 d after MI, suggesting that SMOC1 may be involved in regulation of the inflammatory response. Lack of clear differences in the expression pattern of Hevin at 3 d after MI precludes a significant role for this protein in cardiac rupture or early wound healing after MI. However, further investigation to delineate the specific roles of SPARC-related proteins in the pathogenesis of MI is mandatory.
###end p 54
###begin p 55
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
We found that the total amount of collagen did not differ between SPARC-null and WT infarcts, but Sirius red polarization and electron microscopy revealed a disorganized and immature collagen matrix in the absence of SPARC. Importantly, infarcts from AdSPARC-treated WT mice displayed increased collagen deposition and improved maturation in comparison with infarcts of mice treated with control virus, data which clearly emphasizes the importance of SPARC for appropriate infarct healing.
###end p 55
###begin p 56
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 934 935 930 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 939 940 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
SPARC likely regulates infarct healing and collagen maturation by several different mechanisms. First, SPARC directly interacts with collagen type I fibers (18, 19) and thereby affects their assembly. Variations in the structure of SPARC alter its affinity for collagen type I, and the absence of SPARC results in the formation of immature collagen fibers during wound healing in the skin (6) and in response to a foreign body (20). Moreover, SPARC-null fibroblasts lack the capacity to create a mature collagen matrix as a result of defects in procollagen processing (19). A second mechanism by which SPARC can regulate collagen matrix maturation is the capacity of SPARC to regulate fibronectin matrix assembly (21). In vitro, collagen fibril formation is dependent on the assembly of fibronectin into fibrils (22). Previous studies revealed that lack of SPARC results in impaired fibronectin unfolding, which is regulated via alpha5beta1 integrin and integrin-linked kinase, that could lead to the defective collagen maturation.
###end p 56
###begin p 57
###xml 326 328 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 590 592 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 594 596 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 911 913 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 930 931 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1042 1047 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
In this paper, we provide data that SPARC-mediated TGF-beta1 signaling is important in regulating infarct healing in the heart. TGF-beta1 is a cytokine involved in wound healing and collagen production, which produces multiple, and often opposing, cellular responses throughout the different phases of wound healing after MI (12). Two independent studies demonstrated that early inhibition of TGF-beta signaling increased mortality and exacerbated LV dilatation and contractile dysfunction after MI, whereas blocking TGF-beta signaling during a later phase prevented adverse LV remodeling (23, 24). We have now shown that SPARC regulates TGF-beta signaling in cardiac fibroblasts and demonstrate that the increased TGF-beta signaling in the infarct is beneficial for strengthening of the infarct scar. These findings are concordant with previous observations of SPARC-mediated TGF-beta signaling in epithelial (25) and mesangial (8) cells. Our finding that treatment with TGF-beta prevented infarct rupture and rescued collagen maturation in SPARC-null mice, but did not significantly affect infarct healing in WT animals, provides strong evidence in vivo for an important role for SPARC-mediated TGF-beta signaling in infarct healing and collagen maturation after MI.
###end p 57
###begin p 58
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
The importance of matricellular proteins and proteoglycans in cardiac wound healing and remodeling has previously been noted (26). These macromolecules, which are minimally expressed in the normal uninjured heart, are highly up-regulated in the injured heart. Recent publications have described roles for thrombospondin-1 (27), osteopontin (28), tenascin-C (29), and syndecan-1 (30) in wound healing of the infarcted heart. Thrombospondin-1 and syndecan-1, which are expressed early after MI, serve as a "barrier" limiting the influx of inflammatory cells and thereby regulate proper infarct healing and prevent infarct expansion and cardiac dilatation. In contrast, osteopontin (3, 28), tenascin-C (29), and SPARC (3, 4) are expressed principally during the formation of granulation tissue and fibrous scar and are implicated in the assembly and maturation of collagen fibers.
###end p 58
###begin p 59
In conclusion, this is the first study to reveal that expression of SPARC after MI is essential for proper infarct healing and function after MI. SPARC should be considered as a novel therapeutic agent to improve cardiac remodeling and function after MI.
###end p 59
###begin title 60
MATERIALS AND METHODS
###end title 60
###begin title 61
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of MI.
###end title 61
###begin p 62
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
All described study protocols were approved by the Animal Care and Use Committee of the University of Maastricht and Leuven. Experiments were performed according to the official rules formulated in the Dutch and Belgian law on care and use of experimental animals. 130 10-18-wk-old male and female SPARC-null mice (backcrossed 10 times) and WT animals on a C57Bl6/J background were used in this study, and all experiments were performed using age-matched mice. Experimental MI and sham operation were performed as previously described (16). Hearts were perfused with PBS, removed, and prepared for molecular, histological, and ultrastructural analysis.
###end p 62
###begin title 63
Histology and electron microscopy.
###end title 63
###begin p 64
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 920 921 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Cardiac tissue was processed and histochemical and immunohistochemical analyses were performed as previously described (16, 30). Percentage of infarct size was expressed as the fractional circumference of the infarcted versus infarcted plus noninfarcted left ventricular wall and septum, which was assessed by measuring the midline circumference of three sections of the LV on hemalum eosin-stained sections. Infarct thickness (in micrometers) was measured as the mean of 20 measurements across the infarcted LV wall. Residual necrotic area was determined as the percentage of the total infarcted area. Myofibroblast infiltration was studied as the fractional areas of the infarct stained for alpha-SMC actin (DAKO), excluding coronary vessels. The number of CD-45-staining cells (BD), CD-31-staining capillaries (BD), and alpha-SMC actin-positive coronary vessels (Sigma-Aldrich) in the infarct zone was measured per mm2. For colocalization studies, sections were subsequently incubated with Biotin-labeled secondary antibodies followed by amplification with the signal amplification system (streptavidin-HRP-C-fluorescein/Cy3; PerkinElmer) for SPARC (R&D Systems), CD45, and alpha-SMC. Nuclei were stained with DAPI (Invitrogen).
###end p 64
###begin p 65
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
To assess the quality of the newly formed collagen matrix, Sirius Red staining was performed as previously described (30, 31). The quality of the newly deposited collagen matrix was studied with Sirius Red polarization microscopy, quantifying the ratio of the thick closely packed mature collagen fibers as orange-red birefringent to the loosely packed less cross-linked and immature collagen fibers as yellow-green birefringent (orange-red/yellow-green ratio).
###end p 65
###begin p 66
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
All morphometric analyses were done in a standard way on two midsagittal sections of each heart. Morphometric analyses were performed using a microscope (Leitz DMRXE; Leica), and QWin morphometry software (Leica). Ultrastructural analysis was performed as previously described (20). All analyses were performed according to standard operating procedures and confirmed by independent observers blinded to genotype or treatment group.
###end p 66
###begin title 67
Cardiac fibroblast culture and lentiviral constructs.
###end title 67
###begin p 68
###xml 275 280 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 418 420 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 825 830 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 945 950 939 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 62 66 <span type="species:ncbi:10116">rats</span>
###xml 888 891 <span type="species:ncbi:10116">rat</span>
Cardiac fibroblasts were isolated from 2-d-old neonatal Lewis rats. All the experiments were performed on second-passage cells. Cells were maintained in DME supplemented with 10% FBS and 0.1% gentamycin and were incubated at 37degreesC in a humidified chamber. shRNA against SPARC was produced from small interfering RNA (Eurogentec; Table S3, available at ) and cloned into the XhoI and HpaI sites of pLenti Lox 3.7 (32), and constructs were verified by sequencing. This vector was modified from the pLenti Lox 3.7 vector by replacement of the enhanced GFP gene by puromycin. Lentiviral production was performed by cotransfection of shSPARC/pLL3.7 or empty pLL3.7 puro with packaging vectors into 293FT cells by the use of Lipofectamine 2000 (Invitrogen). Virus-containing supernates were collected after 48 h. Reduction of SPARC mRNA in cardiac fibroblasts was achieved by treatment of rat fibroblasts with lentivirus containing shRNA against SPARC for 48 h. After selection in puromycin, cells were placed in medium containing 0.4% FBS for 24 h. Thereafter, fibroblasts were treated with 1 ng/ml TGF-beta for 15 min.
###end p 68
###begin p 69
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Recombinant SPARC protein was produced by infection of CHO cells with adenovirus containing mouse SPARC. Serum-free media of these cells were collected, purified, and concentrated as described previously (33). Cardiac fibroblasts were placed in medium containing 0.4% FBS for 24 h, after which time 30 mug/ml of recombinant SPARC was added for 1 h. Hereafter, the cells were incubated with 1 ng/ml TGF-beta for 15 min.
###end p 69
###begin title 70
Western blotting.
###end title 70
###begin p 71
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
Infarcted tissue or cell lysates were resolved by SDS-PAGE and were subsequently immunoblotted for the detection of phosphorylated and total Smad2 (Cell Signaling Technology), SPARC (R&D systems), and GAPDH (Research Diagnostics, Inc.) as previously described (34). GAPDH was used as a loading control.
###end p 71
###begin title 72
RNA isolation and expression.
###end title 72
###begin p 73
###xml 390 401 384 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyclophilin</italic>
###xml 405 436 399 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acidic ribosomal phosphoprotein</italic>
RNA was isolated from infarcted and sham tissue with the RNeasy Mini kit (QIAGEN) and was stored at -80degreesC. RNA was reverse transcribed into complementary DNA with the iScript cDNA synthesis kit (Bio-Rad Laboratories). Real-time quantitative PCR was performed with iQ SYBR green supermix (Bio-Rad Laboratories). Primers were designed with Primer Express software (Applied Biosystems). Cyclophilin or acidic ribosomal phosphoprotein was used as a housekeeping gene. The primers used are shown in Table S4 (available at ).
###end p 73
###begin title 74
Echocardiography and functional assessments.
###end title 74
###begin p 75
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
After sedation of mice with 2% isoflurane, standard views were obtained in two-dimensional and M mode by transthoracic echocardiography with a 13-MHz transducer (i13L; GE Healthcare) on a GE Vivid7 (GE Healthcare) echocardiograph. Cardiac function was assessed with increasing dosages of dobutamine in intact female SPARC-null and WT mice 14 d after surgery under 2.5 g/kg urethane i.p. anesthesia as previously described (34).
###end p 75
###begin title 76
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
Adenoviral overexpression of SPARC.
###end title 76
###begin p 77
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
SPARC overexpression was achieved by adenoviral infection of WT mice. The design of the adenoviral vector is described by Barker et al. (21). Adenovirus was produced by 293 cells that were collected and purified as previously described (35). 109 adenoviral PFU was injected into the tail vein 2 d before the onset of acute MI to achieve high levels of SPARC at the onset of MI. 1 d before MI, baseline echocardiography was performed. 2 wk after MI, echocardiography was performed and the mice were killed, after which histological and molecular analysis of infarcted hearts was performed. Overexpression of SPARC was shown by immunoblotting of the plasma of mice that had been treated with SPARC adenovirus.
###end p 77
###begin title 78
###xml 39 43 <span type="species:ncbi:10090">mice</span>
TGF-beta infusion in SPARC-null and WT mice.
###end title 78
###begin p 79
###xml 133 137 <span type="species:ncbi:10090">mice</span>
To investigate whether exogenous administration of TGF-beta rescued increased cardiac rupture after MI, we treated SPARC-null and WT mice with 250 ng/d TGF-beta versus saline for 7 d using osmotic minipumps.
###end p 79
###begin title 80
Statistical analysis.
###end title 80
###begin p 81
###xml 375 376 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Data were expressed as the mean +/- SEM. No repeated measures were performed. Echocardiographic measurements and histological and molecular analysis in sham-operated and infarcted groups at 3, 7, and 14 d were performed in independent groups. Normal distribution of all continuous variables was tested according to the method of Kolmogorov and Smirnov. An unpaired Student's t test was used in most of the comparisons when groups passed the normality test.
###end p 81
###begin p 82
A Mann-Whitney test was used when the SD of two groups significantly differed. A two-way ANOVA was used for comparison of the dobutamine curves. Survival curves after MI were obtained by the Kaplan-Meier method and compared by the log-rank test. A two-sided p-value of <0.05 was considered statistically significant.
###end p 82
###begin title 83
Online supplemental material.
###end title 83
###begin p 84
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
Table S1 shows the transcript levels of ECM mRNAs in sham and infarcted WT and SPARC-null mice. Table S2 shows the transcript levels of ECM mRNAs in sham and infarcted AdR5- and AdSPARC-treated WT mice, confirming increased ECM deposition in AdSPARC-treated infarcts. Table S3 shows the sequences used for the creation of shRNA against SPARC. Table S4 shows the primers used with real-time PCR. Online supplemental material is available at .
###end p 84
###begin title 85
Supplementary Material
###end title 85
###begin title 86
[Supplemental Material Index]
###end title 86
###begin p 87
This study was supported by a research grant of the Netherlands Heart Foundation (NHS; 2005B082, 2007B036, and 2008B011) to S. Heymans, an Ingenious Hypercare NoE EU grant to S. Heymans, a Research grant of the Research fund K.U. Leuven (PDMK/08/175) to D. Vanhoutte, and National Institutes of Health grant GM-40711 to E.H. Sage. Y.M. Pinto is an established investigator of the Netherlands Heart Foundation.
###end p 87
###begin p 88
The authors have no conflicting financial interests.
###end p 88

